Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00387660
What this trial is testing

Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of California, Davis 80
Testing effectiveness (Phase 2)Study completedNCT04010357
What this trial is testing

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Who this might be right for
Small-cell Lung CancerLarge Cell Neuroendocrine Carcinoma of the LungExtrapulmonary Small Cell Carcinoma
Case Comprehensive Cancer Center 14
Early research (Phase 1)Active Not RecruitingNCT06898957
What this trial is testing

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Amgen 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06620796
What this trial is testing

A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
Shanghai Pulmonary Hospital, Shanghai, China 70
Testing effectiveness (Phase 2)WithdrawnNCT00104754
What this trial is testing

Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Not applicableLooking for participantsNCT06529081
What this trial is testing

Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Copernicus Memorial Hospital 165
Testing effectiveness (Phase 2)Study completedNCT03417895
What this trial is testing

SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 59
Not applicableUnknownNCT06267170
What this trial is testing

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC,Extensive Stage
Henan Cancer Hospital 288
Testing effectiveness (Phase 2)Looking for participantsNCT04919382
What this trial is testing

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma+3 more
Dwight Owen 56
Testing effectiveness (Phase 2)Study completedNCT05505825
What this trial is testing

AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC,Extensive Stage
Akeso 36
Testing effectiveness (Phase 2)Looking for participantsNCT06749691
What this trial is testing

Liposomal Irinotecan and Apatinib in ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT00049218
What this trial is testing

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 56
Testing effectiveness (Phase 2)UnknownNCT00546130
What this trial is testing

Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
University of Toyama 45
Not applicableLooking for participantsNCT04790253
What this trial is testing

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

Who this might be right for
Limited Stage Small Cell Lung CancerExtensive-stage Small-cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 600
Testing effectiveness (Phase 2)Looking for participantsNCT06223711
What this trial is testing

Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Universität des Saarlandes 43
Testing effectiveness (Phase 2)Looking for participantsNCT05903092
What this trial is testing

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerSCLCExtensive Stage Small Cell Lung Cancer+1 more
Hirva Mamdani 84
Early research (Phase 1)Active Not RecruitingNCT04560972
What this trial is testing

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
City of Hope Medical Center 3
Testing effectiveness (Phase 2)UnknownNCT05728619
What this trial is testing

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Recurrent Extensive Stage Small Cell Lung Carcinoma
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. 64
Large-scale testing (Phase 3)Active Not RecruitingNCT03043872
What this trial is testing

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 987
Next Page